Telangana Drugs Control Administration (DCA), on Wednesday, cancelled the product manufacturing licence of global pharmaceutical company Mylan Laboratories Limited for ‘alprazolam’, a sedative used to treat anxiety and sleeping disorders.
In the order letter dated February 13, issued by DCA, a copy of which is in possession of The Hindu, P. Sarala, Deputy Director, Nizamabad Licencing Authority “cancelled the drug manufacturing licence, that was issued for the substance ‘Alprazolam’ under Form-25 bearing Licence No. 108/MD/AP/97/B/R (for all specification types) with immediate effect in the larger public interest”. This was done under Section 85(2) in The Drugs and Cosmetics Rules, 1945.
The order comes on the back of unauthorised diversion of 21.25 kilograms of the drug from the licensed premises of the pharmaceutical major in Sangareddy, Telangana, through certain employees who were working as chemists and production officers at the site, V. B. Kamalasan Reddy, Director General, DCA explained. “In connection with this, a seizure of 4.85 kilograms of alprazolam was carried out in February 2023 by Prohibition & Excise Authorities from the consumables room of the pharmaceutical major,“ he added.